Paper |
Title |
Page |
TUPRI002 |
The EUROnu Study for Future High Power Neutrino Oscillation Facilities |
1553 |
|
- T.R. Edgecock
STFC/RAL, Chilton, Didcot, Oxon, United Kingdom
|
|
|
The EUROnu project was a 4 year FP7 design study to investigate and compare three possible options for future, high power neutrino oscillation facilities in Europe. These three facilities are a Neutrino Factory, a neutrino superbeam from CERN to the Frejus Laboratory and a so-called Beta Beam. The study was completed at the end of 2012 and has produced conceptual designs for the facilities and preliminary cost estimates. The designs were used to determine the physics performance. These have been used to compare the facilities. This paper will describe the designs, physics performance and costs and summarise the recommendations of the study.
|
|
DOI • |
reference for this paper
※ https://doi.org/10.18429/JACoW-IPAC2014-TUPRI002
|
|
Export • |
reference for this paper using
※ BibTeX,
※ LaTeX,
※ Text/Word,
※ RIS,
※ EndNote (xml)
|
|
|
WEPRO099 |
A Study of the Production of Neutrons for Boron Neutron Capture Therapy using a Proton Accelerator |
2195 |
|
- T.R. Edgecock
University of Huddersfield, Huddersfield, United Kingdom
- J.R.J. Bennett
STFC/RAL/ISIS, Chilton, Didcot, Oxon, United Kingdom
- S. Green
University Birmingham, Birmingham, United Kingdom
- B. Phoenix, M.C. Scott
Birmingham University, Birmingham, United Kingdom
|
|
|
Boron Neutron Capture Therapy (BNCT) is a binary cancer therapy particularly well-suited to treating aggressive tumours that exhibit a high degree of infiltration of the surrounding healthy tissue. Such tumours, for example of the brain and lung, provide some of the most challenging problems in oncology. The first element of the therapy is boron-10 which is preferentially introduced into the cancerous cells using a carrier compound. Boron-10 has a very high capture cross-section with the other element of the therapy, thermal neutrons, resulting in the production of a lithium nucleus and an alpha particle which destroy the cell they are created in. However, a large flux of neutrons is required and until recently the only source used was a nuclear reactor. In Birmingham, studies of an existing BNCT facility using a 2.8 MeV proton beam and a solid lithium target have found a way to increase the beam power to a sufficient level to allow clinical trials, while maintaining the target solid. In this paper, we will introduce BNCT, describe the work in Birmingham and compare with other accelerator-driven BNCT projects around the World.
|
|
DOI • |
reference for this paper
※ https://doi.org/10.18429/JACoW-IPAC2014-WEPRO099
|
|
Export • |
reference for this paper using
※ BibTeX,
※ LaTeX,
※ Text/Word,
※ RIS,
※ EndNote (xml)
|
|
|
THPRI082 |
Power Upgrade Studies for the ISIS-TS1 Spallation Target |
3961 |
|
- C. Bungau, A. Bungau, R. Cywinski, T.R. Edgecock
University of Huddersfield, Huddersfield, United Kingdom
|
|
|
ISIS is one of the world's most powerful spallation neutron sources for the study of material structures and dynamics. Currently ISIS has two spallation targets, TS1 operating at proton beam powers of up to 200kW, and TS2 operating to 45kW. This paper focuses upon an upgrade study of TS1 with the goal of increasing the ultimate operating power to 1 MW and beyond. During this study we have taken into consideration the necessity of maintaining the spallation neutron pulse width at current values. The increased heat deposition was monitored and the target plates dimensions were modified to take this into account.
|
|
DOI • |
reference for this paper
※ https://doi.org/10.18429/JACoW-IPAC2014-THPRI082
|
|
Export • |
reference for this paper using
※ BibTeX,
※ LaTeX,
※ Text/Word,
※ RIS,
※ EndNote (xml)
|
|
|